Continuous Infusion versus Intermittent Flushing to Prevent Loss of Function of Peripheral Intravenous Catheters used for Drug Administration in Newborn Infants (Review) by Flint, A. et al.
Continuous infusion versus intermittent flushing to prevent
loss of function of peripheral intravenous catheters used for
drug administration in newborn infants (Review)
Flint A, McIntosh D, Davies MW
This is a reprint of a Cochrane review, prepared and maintained by The Cochrane Collaboration and published in The Cochrane Library
2006, Issue 1
http://www.thecochranelibrary.com
1Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug
administration in newborn infants (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
T A B L E O F C O N T E N T S
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW . . . . . . . . . . . . . . . . . .
3SEARCH METHODS FOR IDENTIFICATION OF STUDIES . . . . . . . . . . . . . . . . . . .
3METHODS OF THE REVIEW . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4DESCRIPTION OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
4METHODOLOGICAL QUALITY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
5RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7POTENTIAL CONFLICT OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . .
7ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
7SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
8Characteristics of included studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Characteristics of excluded studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
10Comparison 01. Continuous infusion versus intermittent flushing . . . . . . . . . . . . . . . . . .
10COVER SHEET . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11GRAPHS AND OTHER TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
11Analysis 01.01. Comparison 01 Continuous infusion versus intermittent flushing, Outcome 01 Duration of cannula
patency for the first cannula used per infant (hours) . . . . . . . . . . . . . . . . . . . . .
12Analysis 01.02. Comparison 01 Continuous infusion versus intermittent flushing, Outcome 02 Number of cannulas
used per infant in the first 48 hours . . . . . . . . . . . . . . . . . . . . . . . . . .
iContinuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug
administration in newborn infants (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Continuous infusion versus intermittent flushing to prevent
loss of function of peripheral intravenous catheters used for
drug administration in newborn infants (Review)
Flint A, McIntosh D, Davies MW
This record should be cited as:
Flint A, McIntosh D, Davies MW. Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous
catheters used for drug administration in newborn infants. The Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.:
CD004593.pub2. DOI: 10.1002/14651858.CD004593.pub2.
This version first published online: 19 October 2005 in Issue 4, 2005.
Date of most recent substantive amendment: 12 July 2005
A B S T R A C T
Background
The use of peripheral intravenous cannulae is common in newborn babies. Many of them require an intravenous line only for medications
and not for fluid. Currently there is little uniformity in methods used to maintain cannula patency.
Objectives
The object of this review was to determine which method was better for maintaining intravenous lines used in neonates for intravenous
medication only: intermittent flushing or continuous infusion
Search strategy
We searched The Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2, 2004), CINAHL (from
1982 to June 2004) and MEDLINE (from 1966 to June 2004) .
Selection criteria
Randomised controlled trials comparing continuous infusion to intermittent flushing to maintain patency of intravenous cannulas.
Units of randomisation might include individual catheters or individual babies.
Data collection and analysis
Three reviewers independently assessed trial quality and extracted data.
Main results
Two studies were eligible for inclusion. In one study only one of our primary outcomes was available: the duration of cannula patency
for the first cannula used per infant was slightly longer in the continuous infusion group, but not significantly so, with a mean difference
of -4.3 hours (95% CI -18.2 to 9.7).
In the second study, only one of our primary outcomes was available: the mean (SD) number cannulas used per infant in the first
48 hours was less in the intermittent flush group with a mean difference of -0.76 cannulas (95% CI -1.37 to -0.15). No results were
available for any of our other primary outcomes: in the published report, results were reported per catheter rather than per infant, a
number of infants received more than one intravenous catheter (39 infants received an unknown number of catheters). The overall
duration of cannula patency was significantly longer in the intermittent flush group with a mean duration of patency in the intermittent
flush group of 2.1 days (SD 1.0) compared with the continuous infusion group where the mean duration of patency was 1.0 days (SD
0.5) - Student’s t test P value 0.0003.
Authors’ conclusions
It is difficult to draw reliable conclusions given the way the data were analysed and reported in the two included studies. The reliability
of the results is uncertain. However, given the caution in interpreting these data, it should also be noted that the use of intermittent
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flushes was not associated in either study with a decreased cannula life or any other disadvantages, thus lending some support for the
use of intermittent flushing of cannulas in a selected population in neonatal nurseries.
P L A I N L A N G U A G E S U M M A R Y
The best way to keep a newborn baby’s intravenous line working is still unknown.
We aimed to find out which was the better way to keep a newborn baby’s intravenous line open and working -- either running a
continuous amount of intravenous fluid through it (continuous infusion) or giving a small amount of fluid through it every few hours
(intermittent flush) only. One study showed no difference between the two approaches for keeping a baby’s intravenous line open and
working and one study showed an advantage for intermittent flushes. The studies, however, had some problems in how the data were
analysed and reported. Therefore, we are uncertain as to how reliable the results are and further research should be undertaken.
B A C K G R O U N D
Peripheral intravenous cannula use is common in newborn babies
admitted to neonatal nurseries (Ward 1993). A significant number
of these babies only require intermittent intravenous drug therapy
and do not require supplemental fluids or other continuous drug
infusions. Intravenous cannulation and therapy may require the
baby to be separated from its mother, at least initially, and can delay
the establishment of maternal infant bonding (Malcolm 2000;
WHO 1998).
Insertion of peripheral intravenous cannulas in neonates can be a
stressful experience for the baby, the new parent and the medical/
nursing staff (Yeo 1998; Olds 2000; Cotton 1998). It is therefore
desirable once the intravenous cannula is inserted that its patency
be maintained for as long as possible. Each cannula should last as
long as possible and for any given period of treatment a minimum
number of cannulas should be used. To achieve this the cannula
can be infused continuously with fluid at a low rate or flushed
intermittently (usually every 4-8 hours) (Cotton 1998).
Continuous infusions require more nursing time and equipment
and impede access of the mother to the infant but the cannula
might last longer and have fewer complications such as extravasa-
tion or dislodgment. Intermittent flushing would decrease nursing
time and equipment and allow greater access of the mother to her
infant, but may decrease cannula life by blockage due to clotting.
Currently there is little uniformity between neonatal nurseries as
to which method is used and evidence is required to decide which
method, if any, best maintains intravenous access.
There is limited evidence that the following factors may increase
the risk of intravenous cannula failure: certain drugs (such as gen-
tamicin or aminophylline) (Moclair 1995); size of cannula (Danek
1992).
A different question as to whether the continuous infusion fluid
or the intermittent flush solution should contain heparin has been
considered in a separate Cochrane review (Shah 2004). Shah et
al concluded that “no conclusive evidence is available...to evalu-
ate the effectiveness of heparin to prolong PIV [peripheral intra-
venous] cannula life in the neonatal population”. Only eight eligi-
ble studies were identified and only five commented on duration
of catheter use. Due to significant clinical heterogeneity and het-
erogeneity in treatment effect no recommendation could be made
as to whether use of heparin was advisable or not without further
research.
As with all invasive procedures, there is a significant risk of in-
troducing infection into the newborn when inserting a peripheral
intravenous catheter. Septicaemia, although an infrequent com-
plication could potentially have a lethal outcome. It is therefore
desirable that catheter patency be maintained as long as possible
thus reducing the number of skin breakages made in the baby and
ultimately decreasing the risk of infection.
O B J E C T I V E S
Primary Objectives
• To determine whether continuous infusion or intermittent
flushing is better with regard to maintaining patency of intra-
venous cannulas.
Secondary Objectives
• To determine which method resulted in fewer complications
(infection, dislodgment, extravasation, phlebitis).
• To determine which method has the greater cost.
• To determine which method is better for reducing the time to
initiate and attain full suck feeding.
We also aim to determine if the outcomes above were different by:
• Which drug is being administered (antibiotics versus non an-
tibiotics, aminoglycosides versus non aminoglycosides)
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• The size of the cannula used for intravenous therapy (24G or
smaller versus 22G or bigger)
C R I T E R I A F O R C O N S I D E R I N G
S T U D I E S F O R T H I S R E V I E W
Types of studies
Only randomised controlled trials of adequate quality in which
continuous infusion is compared to intermittent flushing to main-
tain patency of intravenous cannulas in neonates will be included.
Quasi randomised studies will not be used. Units of randomisa-
tion might include individual catheters or individual babies.
Types of participants
Newborn infants receiving intermittent intravenous drug treat-
ment but not for continuous drug infusions or supplemental flu-
ids.
Newborn infants are: term infants < 29 days old, preterm infants
up to a corrected age of 44 weeks, or infants cared for in a neonatal
unit.
Types of intervention
Continuous infusion of peripheral intravenous catheters with dex-
trose and/or saline solutions, with or without heparin.
Intermittent flushes of peripheral intravenous catheters with saline
or heparinised saline given at intervals greater than every second
hour.
Studies which allow the use of peripheral intravenous catheters for
blood sampling will not be included.
Types of outcome measures
Primary Outcomes
• Duration of cannula patency (hours) for the first cannula used
per infant
• Number of cannulas used during primary treatment course in
individual infants
• Number of cannulas used during first 48 hours in individual
infants
Secondary Outcomes
• Duration of cannula patency (hours) in individual infants (for
all cannulas as averaged during the treatment course or during
the first 24, 48, 72 hours of treatment )







• Mortality (at discharge, 28 days or one year)
• Proportion of infants with delayed suck feeding (defined as
either i. has not initiated suck feeding within 12 hours of birth,
ii. requires supplemental nasogastric tube feeding)
• Proportion of infants not breast feeding (at discharge, 28 days,
three months or six months)
• Infections (positive blood cultures or as defined in individual
studies)
• Maternal-infant bonding (however defined in individual stud-
ies)
S E A R C H M E T H O D S F O R
I D E N T I F I C A T I O N O F S T U D I E S
See: Neonatal Group methods used in reviews.
The standard search strategy for the Cochrane Neonatal Review
Group was used. See: Neonatal Review Group search strategy.
We searched the following electronic databases: The Cochrane
Central Register of Controlled Trials (CENTRAL, The Cochrane
Library, Issue 2, 2004), CINAHL (from 1982 - June 2004 ) and
MEDLINE (from 1966 - June 2004).
Searches of the electronic databases were based on the following
search terms:
MeSH terms: infusions, intravenous OR injections, intravenous;
OR text words: “IV treatment” OR “IV therapy” OR “IV drug”
OR “IV medication” OR “intravenous treatment” OR “intra-
venous therapy” OR “intravenous drug” OR “intravenous medi-
cation” OR “intra-venous treatment” OR “intra-venous therapy”
OR “intra-venous drug” OR “intra-venous medication”;
NOT MeSH term: Substance Abuse, Intravenous.
AND
MeSH term: infant, newborn OR text word “neonate”
AND
The highly sensitive search strategy developed by Kay Dickersin
to identify RCTs (Dickersin 1994)
We also searched previous reviews including cross references. We
also used the results of searches of abstracts, conference and sym-
posia proceedings as done by the Cochrane Neonatal Review
Group. No language restrictions were applied. Published or un-
published data were considered.
M E T H O D S O F T H E R E V I E W
Criteria and methods used to assess the methodological quality of
the trials: standard methods of the Cochrane Collaboration and
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its Neonatal Review Group were used. At least two of the review-
ers worked independently to search for and assess trials for inclu-
sion and methodological quality. Studies were assessed using the
following key criteria: allocation concealment (blinding of ran-
domisation), blinding of intervention, completeness of follow up
and blinding of outcome measurement. The reviewers extracted
data independently. Differences were resolved by discussion. An
attempt was made to contact study investigators for additional in-
formation or data.
Data analysis:
For individual trials: for continuous variables such as duration of
cannula patency, mean differences, and 95% confidence intervals
were to be reported. For categorical outcomes such as mortality, the
relative risks (RR) and 95% confidence intervals will be reported.
For pooled results: for continuous variables, weighted mean dif-
ferences (WMD) and 95% confidence intervals will be reported.
For categorical outcomes, the relative risks (RR) and 95% confi-
dence intervals will be reported. For significant findings, the risk
difference (RD) and number needed to treat (NNT) will also to be
reported. Each treatment effect will be tested for heterogeneity to
help determine suitability for pooling of results in a meta-analysis.
The fixed effects model will be used for meta-analysis.
D E S C R I P T I O N O F S T U D I E S
Two studies were identified for inclusion in this review (Kalyn
2000; Taylor 1989). Methods and clinical details including par-
ticipants, interventions and outcomes are given in Table 1.
Included studies
Kalyn et al (Kalyn 2000) performed a multi-centre randomised
controlled trial. Infants were randomised either to a continuous
infusion of 0.5-1 mL/hr of 10% Dextrose or intermittent flushes
with 0.5-1 mL every 6 hrs of 0.9% non heparinised saline. The
infants were randomly assigned to their groups using a computer
generated random number. Blinding of the interventions was ob-
viously not done. Infants receiving intermittent drug therapies via
a peripheral intravenous catheter were eligible for inclusion in the
study but infants receiving continuous drug infusions or supple-
mental fluids were not. A total of 95 neonates (42 to intermittent
flush group and 53 to continuous infusion group) were cannulated
with 238 catheters (84 to intermittent flush group and 154 to the
continuous infusion group) during the study period. The primary
diagnosis for all the infants was sepsis. Follow-up continued until
the intravenous catheter was either removed because intravenous
medication was stopped or the catheter was no longer working;
the infant was transferred elsewhere; or the infant required main-
tenance intravenous fluids. The two groups were all well matched
for demographic and clinical variables, including birth weight,
gestational age, the site and size of the catheters and types of drugs
being administered. The duration of patency of each catheter was
recorded as well as the reasons for loss of patency: phlebitis, oc-
clusion, leaking and infiltration. The outcomes were reported per
catheter used.
Taylor et al (Taylor 1989) did a randomised controlled trial in
infants who were admitted to the ’intermediate care’ nursery who
either:
1. required intravenous medications but no additional intravenous
fluids, or
2. had an umbilical arterial catheter in situ and required an intra-
venous cannula for medications.
The infants were randomised either to a continuous infusion group
where the intravenous line was kept patent by a continuous in-
fusion of 10% dextrose (without heparin) at a rate of 1.5 to 3.0
ml/hr; or intermittent flushes where the intravenous cannula was
kept patent with a heparin lock (0.5 ml of heparinised saline) given
every six hours or after injection of medications. The method of
randomisation was not stated. Blinding of the interventions was
obviously not done. One infant in the intermittent flush group was
excluded post randomisation because the “... catheter was needed
only briefly, not allowing for time for data collection”. Data were
collected on a total of 39 neonates (22 to intermittent flush group
and 17 to continuous infusion group) who were cannulated with
an unknown number of catheters. The infants were enrolled in the
study until they no longer required intravenous access. The two
groups were all well matched for demographic and clinical vari-
ables, including birth weight and gestational age. Outcome mea-
sures included the number of days the infant was enrolled in the
study; quantitation of parental medications, blood products and
intravenous fluids; number of line infiltrations; duration of can-
nula patency (this seemed to have been measured for each cannula
regardless of the number used in each infant); and the number of
times the infant was removed from the incubator to be held by a
nurse or parent.
Excluded Studies
A number of studies were found which examined the duration of
peripheral intravenous catheter patency with or without heparin
intermittent flushes (Danek 1992; Hanrahan 2000; LeDuc 1997;
McMullen 1993; Nelson 1998). However, none compared inter-
mittent flushes with continuous infusions and were therefore not
included in the review. This is the subject of another review by
Shah et al (Shah 2004).
M E T H O D O L O G I C A L Q U A L I T Y
Kalyn’s study (Kalyn 2000): the randomisation method was by a
computer generated random number to assign infants by alternate
sequential series; allocation was performed in a blind manner by
using sealed opaque envelopes to assign each infant to either group;
blinding of intervention was not done; follow-up was complete
and outcome assessments were not blinded.
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Taylor’s study (Taylor 1989): the randomisation method was not
stated; allocation was performed in a blind manner by using sealed
opaque envelopes to assign each infant to either group; blinding of
intervention was not done; follow-up was complete and outcome
assessments were not blinded.
R E S U L T S
Two studies (Kalyn 2000; Taylor 1989) were eligible for inclusion.
Kalyn 2000
The lead author of Kalyn et al (Kalyn 2000) was contacted for fur-
ther information regarding this study: additional data were avail-
able on the duration of patency for the first catheter used per in-
fant.
Primary outcomes
• Duration of cannula patency for the first cannula used per infant
was slightly longer in the continuous infusion group, but not
significantly so, with a mean difference of -4.3 hours (95% CI
-18.2 to 9.7). These unpublished data were provided by the lead
author of the study (Kalyn 2000).
• Number of cannulas used during primary treatment course in
individual infants - individual outcome not available
• Number of cannulas used during the first 48 hrs in individual
infants - individual outcome not available
Secondary outcomes
• Duration of cannula patency in individual infants for all
catheters as averaged during the treatment course:
In the published report (Kalyn 2000) results were reported per
catheter rather than per infant, a number of infants received more
than one intravenous catheter (95 infants received 238 catheters
in total). No statistically significant difference was found between
the two groups for duration of cannula patency. The mean du-
ration of patency in the intermittent flush group was 45.2 hours
(SD 29.3) and in the continuous infusion group 48.7 hours (SD
41.1) - Mann-Whitney U test P value 0.13. However, whilst the
mean duration of cannula patency in each group was similar, there
were 84 cannulas used in the intermittent flush group and 154
cannulas used in the continuous infusion group. It is difficult to
reconcile that mean duration of cannula use was not different; yet
almost twice as many cannulas were used in the continuous infu-
sion group. The average total duration of cannula use for infants in
the continuous infusion group must have been longer (although
data for this are not available). And therefore any differences be-
tween the two groups is prone to significant bias.
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 24 hours of treatment
- the study did not report on this outcome
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 48 hours of treatment
- the study did not report on this outcome
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 72 hours of treatment
- the study did not report on this outcome
• Proportion of infants with loss of cannula function due to:
-blockage - individual outcome not available
-extravasation - individual outcome not available
-phlebitis - individual outcome not available
-dislodgment - individual outcome not available
-infection - individual outcome not available
A significant difference (Chi squared test P < 0.001) was found
when the two catheter groups were compared with respect to the
removal or loss of patency of catheters. The results were presented
by catheter rather than by infant although it was stated that results
were also analysed by infant and similar results were obtained.
The catheters in the intermittent flush group were less likely to
infiltrate, leak or cause phlebitis (35.7%) than in the continuous
infusion group. The continuous infusion group, however, were
less likely to occlude (9.1%) than the intermittent flush group
(25%). In the intermittent flush group 39% of catheters (com-
pared with 24% in the continuous infusion group) did not have
infiltration/phlebitis/leaking/occlusion because the catheter was
either removed because intravenous medication was stopped, the
infant was transferred elsewhere or the infant required mainte-
nance intravenous fluids.
• Cost (dollars) - individual outcome not available
• Mortality - individual outcome not available
• Proportion of infants with delayed suck feeding - individual
outcome not available
• Infections - individual outcome not available
• Maternal - infant bonding-individual outcome not available
Taylor 1989
The lead author of Taylor et al (Taylor 1989) was contacted for fur-
ther information regarding this study: additional data were avail-
able on post-randomisation exclusions, the number of cannulas
used during the first 48 hours in individual infants, and loss of
cannula function.
Primary outcomes
• Duration of cannula patency for the first cannula - individual
outcome not available
• Number of cannulas used during primary treatment course in
individual infants - individual outcome not available
• Number of cannulas used during the first 48 hrs in individual
infants:
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The mean (SD) number cannulas used per infant in the first 48
hours was 1.59 (0.59) in the intermittent flush group and 2.35
(1.17) in the continuous infusion group. The mean difference was
-0.76 cannulas (95% CI -1.37 to -0.15).
Secondary outcomes
• Duration of cannula patency in individual infants for all
catheters as averaged during the treatment course:
In the published report (Taylor 1989) results were reported per
catheter rather than per infant, a number of infants received more
than one intravenous catheter (39 infants received an unknown
number of catheters). The duration of cannula patency was signif-
icantly longer in the intermittent flush group. The mean duration
of patency in the intermittent flush group was 2.1 days (SD 1.0)
and in the continuous infusion group 1.0 days (SD 0.5) - Student’s
t test P value 0.0003.
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 24 hours of treatment
- the study did not report on this outcome
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 48 hours of treatment
- the study did not report on this outcome
• Duration of cannula patency (hours) in individual infants for
all cannulas as averaged during the first 72 hours of treatment
- the study did not report on this outcome
• Proportion of infants with loss of cannula function due to:
-blockage - outcome not available
-extravasation - outcome not available except for first 48 hours
(see below)
-phlebitis - nil noted in either group
-dislodgment - outcome not available except for first 48 hours
(see below)
-infection - nil noted in either group
The authors reported extravasation (i.e., subcutaneous infiltration)
as the number of infiltrations per day. There was a mean (SD) of
0.7 (0.6) infiltrations per day in the continuous infusion group
and 0.3 (0.2) in the intermittent flush group (Student’s t test P
value 0.0015).
• Cost (dollars) - individual outcome not available
• Mortality - individual outcome not available
• Proportion of infants with delayed suck feeding - individual
outcome not available
• Infections - individual outcome not available
• Maternal - infant bonding-individual outcome not available
The study also reported the following outcomes:
• volume of fluid infused through the cannula - mean (SD) of
28.7 (11) ml/kg/day in the continuous infusion group and 7.7
(6.8) ml/kg/day in the intermittent flush group (Student’s t test
P <0.0001);
• number of times the infant was removed from the incubator by
parent or nurse - mean (SD) of 1.9 (1.3) times per day in the
continuous infusion group and 1.2 (1.5) times per day in the
intermittent flush group (Student’s t test P value 0.2);
• a score consisting of a “subjective evaluation regarding ease of
handling and maintaining intravenous patency” (a scale of 1 to
5 with 1 having maximum ease of handling and maintaining
intravenous patency and 5 having maximum problems with
ease of handling and maintaining intravenous patency) - mean
(SD) score of 3.8 (1.1) in the continuous infusion group and
1.7 (0.7) in the intermittent flush group (Student’s t test P value
0.0001).
Extra information available from the study investigators also in-
clude the following outcomes:
• need for the cannula to be replaced during the entire study
period - 2/17 (12%) infants did not need their cannula to be
replaced in the continuous infusion group, and 8/22 (36%)
infants did not need their cannula replaced in the intermittent
flush group;
• loss of cannula function in the first 48 hours - in the continuous
infusion group 10 cannulas extravasated, two dislodged, five
remained intact; in the intermittent flush group 11 cannulas
extravasated, one dislodged, 10 remained intact.
D I S C U S S I O N
Even though one study showed no difference between the ap-
proaches for maintaining cannula patency and one showed an ad-
vantage for intermittent flushes, it is unfortunate that the way the
data were analysed and reported in the two included studies makes
the reliability of the results uncertain.
The reports (for both included studies) only included as their main
outcome the average duration of cannula patency for all cannulas.
That is, they reported duration of cannula patency for all cannulas
in all infants in each treatment group averaged over the treatment
course. Some infants would have had multiple cannulas and, there-
fore, the mean duration of cannula patency would include multi-
ple measures of the duration of cannula patency in some infants
with non-independence of those multiple measures. This would
invalidate the assumptions necessary to ensure the reliability of the
statistical tests used.
In the study by Kalyn et al (Kalyn 2000) the number of catheters
per number of neonates was difficult to interpret and additional
unpublished data are not available to clarify this. The reasons for
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re-cannulation of individual infants were not recorded in the study.
However, the additional information that was provided by the
study investigators for duration of patency for the first catheter
used per infant did not show any significant difference between
groups for this outcome.
Taylor et al found a longer duration of cannula patency (aver-
aged over all catheters for that infant) with intermittent flushing
and greater ease of handling of those infants. They also found
that the mean number of cannulas used per infant in the first 48
hours was less for intermittent flushing. We had speculated that
a baby requiring intermittent flushing of their intravenous line is
far more portable than one with a continuous infusion line. We
believed that this would make handling, feeding and caring for
baby easier for mothers in neonatal nurseries and enable staff the
opportunity to enhance maternal-infant bonding opportunities.
These outcomes were assessed by Taylor et al (Taylor 1989) using a
subjective nursing score (unblinded assessment) and they did find
that the infants having intermittent flushes were easier to care for.
It should be noted that Taylor et al’s study compared intermittent
flushing of the cannula with heparinised saline with a continuous
infusion that did not contain heparin. The use of heparinised
saline for the intermittent flush used to maintain cannula patency
has been reviewed by Shah et al (Shah 2004). Their systematic
review found five studies that compared intermittent flush with
heparin and intermittent flush without heparin and reported the
outcome of duration of cannula patency for the first cannula used
per infant. There was no consistency of results for this outcome
with two studies showing longer duration with heparin, one study
showing longer duration without heparin and two studies showing
no difference.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
It is difficult to draw reliable conclusions given the way the data
were analysed and reported in the two included studies. The re-
liability of the results is uncertain. However, given the caution
in interpreting these data, it should also be noted that the use
of intermittent flushes was not associated in either study with a
decreased cannula life or any other disadvantages, thus lending
some support for the use of intermittent flushing of cannulas in a
selected population in neonatal nurseries.
Implications for research
Further research is required to examine the duration of cannula
patency comparing the two methods. Outcome assessment and
data analysis should be reported by infant and by cannula (espe-
cially the first cannula used in each infant). Cost analysis would
also be valuable comparing the cost of continuous infusions to
intermittent flushing. Other outcomes that might enhance the in-
teraction between mothers, babies and nursing staff would also be
worthwhile, such as maternal satisfaction and ease of handling for
mothers and nurses.
P O T E N T I A L C O N F L I C T O F
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A C K N O W L E D G E M E N T S
Thank you to Angela Kalyn for providing some additional data
from her study (Kalyn 2000), and to Howard Kilbride for provid-
ing some additional data from his study (Taylor 1989).
S O U R C E S O F S U P P O R T
External sources of support
• Cochrane Perinatal Team, Brisbane AUSTRALIA
Internal sources of support
• Grantley Stable Neonatal Unit, Royal Women’s Hospital, Bris-
bane AUSTRALIA
• Dept of Paediatrics and Child Health, University of Queens-
land, Brisbane AUSTRALIA
• Simpson Centre for Reproductive Health UK
7Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug
administration in newborn infants (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
R E F E R E N C E S
References to studies included in this review
Kalyn 2000 {published data only}
Kalyn A, Blatz S, J Pinelli. A comparison of continuous infusion and
intermittent flushing methods in peripheral intravenous catheters in
neonates. Journal of IV Nursing 2000;23:146–53.
Taylor 1989 {published data only}
Taylor J, Shannon R, Kilbride HW. Heparin lock intravenous line:
use in newborn infants. Clinical Pediatrics 1989;28:237–40.
References to studies excluded from this review
Danek 1992
Danek GD, Noris EM. Pediatric i.v. catheters: efficacy of saline flush.
Pediatric Nursing 1992;18:111–3.
Hanrahan 2000
Hanrahan KS, Kleiber C, Berends S. Saline for peripheral intravenous
locks in neonates: evaluating change in practice. Neonatal Network
2000;19:19–24.
LeDuc 1997
LeDuc K. Efficacy of normal saline solution versus heparin solution
for maintaining patency of peripheral intravenous catheters in chil-
dren. Journal of Emergency Nursing 1997;23:306–9.
McMullen 1993
McMullen A, Fioravanti ID, Pollack V, Rideout K, Sciera M. Hep-
arinized saline or normal saline as a flush solution in intermittent in-
travenous lines in infants and children. MCN. The American Journal
of Maternal Child Nursing 1993;18:78–85.
Nelson 1998
Nelson JJ, Graves SM. 0.9% Sodium chloride injection with and
without heparin for maintaining peripheral indwelling intermittent-




Cotton MC, Turner BS, Miller-Bell M. Pharmacology in neonatal
care. In: Merenstein GB, Gardener SL, editor(s). Handbook of Inten-
sive Care. 5th Edition. St Louis: Mosby, 1998:148–62.
Danek 1992
Danek GD, Noris EM. Pediatric i.v. catheters: efficacy of saline flush.
Pediatric Nursing 1992;18:111–3.
Dickersin 1994
Dickersin K, Scherer R, Lefebvre C. Identifying relevant studies for
systematic reviews. British Medical Journal 1994;309:1286–91.
Malcolm 2000
Malcom IL, Tudehope DI, Thearle MJ. Parent-infant attachment
and support for parents experiencing perinatal loss. In: Malcom IL,
Tudehope DI, Thearle MJ, editor(s). Essentials of neonatal medicine.
3rd Edition. Oxford: Blackwell Science, 2000:297–303.
Moclair 1995
Moclair A, Bates I. The efficacy of heparin in maintaining peripheral
infusions in neonates. European Journal of Pediatrics 1995;154:567–
70.
Olds 2000
Olds SB, London ML, Wieland Ladewig PA. The newborn at risk:
conditions present at birth. In: Olds SB, London ML, Wieland
Ladewig PA, editor(s). Maternal-newborn nursing: a family and
community-based approach. 6th Edition. New Jersey: Prentice Hall
Health, 2000:804–903.
Shah 2004
Shah PS, Ng E, Sinha AK. Heparin for prolonging peripheral intra-
venous catheter use in neonates. In: The Cochrane Database of Sys-
tematic Reviews, 3, 2004.
Ward 1993
Ward R M. Neonatal pharmocology. In: Kenner C, Brueggemeyer A,
Gunderson LP, editor(s). Comprehensive neonatal nursing. 1st Edition.
Philadelphia: W.B.Saunders Company, 1993:926–939.
WHO 1998
Anonymous. Evidence for the ten steps to successful breastfeeding. Re-
vised Edition. Geneva: World Health Organisation, 1998.
Yeo 1998
Yeo H. Stress in the neonatal unit. In: Yeo H, editor(s). Nursing the
Neonate. Oxford: Blackwell Science, 1998:278–92.
∗Indicates the major publication for the study
T A B L E S
Characteristics of included studies
Study Kalyn 2000
Methods Multi-centre randomised controlled trial with treatment group allocation determined by computer generated
randomisation.
Assessment of the following key criteria:
allocation concealment (blinding of randomisation) - yes, group allocation was concealed by opaque en-
velopes;
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Characteristics of included studies (Continued )
blinding of intervention - no;
completeness of follow up - all infants that entered the study were accounted for;
blinding of outcome measurement - no.
Participants Neonates in the neonatal nursery who do not require IV fluids.
Number of infants = 95
-IF=42
-CI=53





Interventions Continuous infusion (CI) using 0.5-1 mL of 10% Dextrose; or
intermittent flushing (IF) using 0.5-1 mL 0.9% normal saline flushed before and after every medication and
every 6 hours.
Outcomes Proportion of catheters with:
1. infiltration, phlebitis or leaking;
2. occlusion;
3. either removal because intravenous medication was stopped, the infant was transferred elsewhere or the
infant required maintenance intravenous fluids.
Notes The infants were randomised and allocated to either group, but the data were analysed and reported by
catheter.
The lead author of this study was contacted for further information regarding this study: additional data
were available on the duration of patency for the first catheter used per infant.
Allocation concealment A
Study Taylor 1989
Methods Randomised controlled trial. The randomisation method was not stated.
Assessment of the following key criteria:
allocation concealment (blinding of randomisation) - yes, group allocation was concealed by opaque en-
velopes;
blinding of intervention - no;
completeness of follow up - all infants that entered the study were accounted for;
blinding of outcome measurement - no.
Participants Newborn infants who were admitted to the ’intermediate care’ nursery who either 1. required intravenous
medications but no additional intravenous fluids, or 2. had an umbilical arterial catheter in situ and required
an intravenous cannula for medications.
Number of infants = 39
-IF=22
-CI=17
Interventions Continuous infusion (CI) using 10% dextrose (without heparin) at a rate of 1.5 to 3.0 ml/hr; or
intermittent flushing (IF) using a heparin lock (0.5 ml of heparinised saline) given every 6 hours or after
injection of medications.
Outcomes Outcome measures included:
the number of days the infant was enrolled in the study;
quantitation of parental medications, blood products and intravenous fluids;
number of line infiltrations;
9Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug
administration in newborn infants (Review)
Copyright © 2006 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd
Characteristics of included studies (Continued )
duration of cannula patency (this seemed to have been measured for each cannula regardless of the number
used in each infant); and






Characteristics of excluded studies
Danek 1992 Did not compare continuous infusion with intermittent flushes.
Hanrahan 2000 Historical cohort comparison only; did not compare continuous infusion with intermittent flushes.
LeDuc 1997 Did not compare continuous infusion with intermittent flushes.
McMullen 1993 Did not compare continuous infusion with intermittent flushes.
Nelson 1998 Did not compare continuous infusion with intermittent flushes.
A N A L Y S E S





participants Statistical method Effect size
01 Duration of cannula patency
for the first cannula used per
infant (hours)
Weighted Mean Difference (Fixed) 95% CI Totals not selected
02 Number of cannulas used per
infant in the first 48 hours
Weighted Mean Difference (Fixed) 95% CI Totals not selected
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Title Continuous infusion versus intermittent flushing to prevent loss of function of peripheral
intravenous catheters used for drug administration in newborn infants
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G R A P H S A N D O T H E R T A B L E S
Analysis 01.01. Comparison 01 Continuous infusion versus intermittent flushing, Outcome 01 Duration of
cannula patency for the first cannula used per infant (hours)
Review: Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug administration in newborn
infants
Comparison: 01 Continuous infusion versus intermittent flushing
Outcome: 01 Duration of cannula patency for the first cannula used per infant (hours)
Study Intermittent flush Continuous infusion Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Kalyn 2000 42 55.39 (31.29) 53 59.66 (37.99) -4.27 [ -18.20, 9.66 ]
-100.0 -50.0 0 50.0 100.0
Favours infusion Favours flush
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Analysis 01.02. Comparison 01 Continuous infusion versus intermittent flushing, Outcome 02 Number of
cannulas used per infant in the first 48 hours
Review: Continuous infusion versus intermittent flushing to prevent loss of function of peripheral intravenous catheters used for drug administration in newborn
infants
Comparison: 01 Continuous infusion versus intermittent flushing
Outcome: 02 Number of cannulas used per infant in the first 48 hours
Study Intermittent flush Continuous infusion Weighted Mean Difference (Fixed) Weighted Mean Difference (Fixed)
N Mean(SD) N Mean(SD) 95% CI 95% CI
Taylor 1989 22 1.59 (0.59) 17 2.35 (1.17) -0.76 [ -1.37, -0.15 ]
-4.0 -2.0 0 2.0 4.0
Favours flush Favours infusion
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